As BAG3 protein is involved in sustaining BRAF levels and ERK phosphorylation in A375 melanoma cells, we sought to verify if BAG3 silencing can affect the response of those cells to prolonged Vemurafenib treatment. The gene discussed is BRAF; the disease is melanoma.